Cytek Biosciences (CTKB) News
NASDAQ: CTKBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
6.12-0.20 (-3.16%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CTKB news summary
We found 7 recent headlines mentioning Cytek Biosciences (CTKB): 1 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. For price context, CTKB is down 3.16% at $6.12. The most recent story, "Cytek Biosciences to Participate in Upcoming Investor Conferences", was published by GlobeNewswire on Nov 18, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Cytek Biosciences headlines
- Cytek Biosciences to Participate in Upcoming Investor ConferencesFREMONT, Calif., Nov. 18, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the…GlobeNewswire
- Cytek Aurora® Evo System Wins BioTech Breakthrough Award for Drug Discovery Innovation of the YearThe Cytek Aurora® Evo system has been named Drug Discovery Innovation of the Year in the 2026 BioTech Breakthrough Awards.GlobeNewswire
- Cytek Biosciences (CTKB) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Cytek Biosciences GAAP EPS of -$0.05 beats by $0.02, revenue of $53.2M beats by $0.25MSeeking Alpha
- Cytek Biosciences Reports Third Quarter 2026 Financial ResultsFREMONT, Calif., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results…GlobeNewswire
- Cytek Biosciences to Participate in Upcoming Investor ConferencesFREMONT, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the…GlobeNewswire
- Cytek Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026FREMONT, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), today announced that it will report financial results for the third quarter…GlobeNewswire